Allgemein

Novel Adaptive Superiority Trial Design of ProtEmbo® Cerebral Embolic Protection (CEP) System

Protembis announces the appointment of Professor J. Mocco to Board of Directors

Azin Parhizgar To Chair Protembis’ New Board of Directors

Protembis announces completion of 20 cases in European CE mark study with the ProtEmbo® Cerebral Protection System Enrollment with advanced generation device for complete cerebral protection nearing halfway mark in clinical study in Germany and Poland Aachen, Germany, February 25, 2021 Protembis GmbH, a privately held emerging medical device company, announced today the successful completion … Weiterlesen …

Aachen-based Startup Company Protembis Successfully Closes $ 10 Million Series A Financing

Protembis Achieves ISO 13485:2016 Quality Management System Certification

Protembis announces successful first-in-human use of its ProtEmbo®Cerebral Protection System in European trial

Protembis Initiates Collaboration with German Accelerator Life Sciences for Planned U.S. Expansion

Medical device company Protembis GmbH has closed its seed financing round